Related Experiment Video
Updated: Aug 5, 2026

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
Early Dose-Related Cardiorenal Effects of Cisplatin: Integrated Biochemical, Molecular and Histopathological
Gülsüm Abuşoğlu1, Melek Altunkaya1, Mehmet Burak Ateş2
1Medical Laboratory Techniques Program, Vocational School of Health Services, Selcuk University, Konya 42130, Turkey.
Abstract:
Background/Objectives: Cisplatin (CP) is a widely used chemotherapeutic agent; however, its dose-dependent effects on different tissues are not fully understood. This study aimed to investigate the early dose-related cardiorenal toxicity of CP at biochemical, molecular, and histopathological levels. Methods: Male Wistar albino rats were divided into four groups: Control, 5 mg/kg CP, 7.5 mg/kg CP, and 12 mg/kg CP. Cardiac and renal tissues were collected three days after administration. Oxidative stress and inflammatory parameters were analyzed using ELISA. Histopathological evaluation and semi-quantitative scoring were performed on tissue sections. Apoptosis-related proteins were assessed using Western blotting and immunohistochemistry. Results: In both renal and cardiac tissues, LPO, MDA, and SOD levels showed significant dose-dependent changes, whereas inflammatory parameters did not differ significantly among the groups. Although Bax and Bcl-2 proteins displayed significant dose-dependent variations in both tissues at the protein level, immunohistochemical analyses showed no notable differences in cardiac tissue. Conclusions: Acute cisplatin exposure produced dose-related biochemical, molecular, and histopathological alterations in both cardiac and renal tissues. Oxidative stress-related changes were more prominent than cytokine-mediated inflammatory responses during the acute experimental period. Within the conditions of this acute model, lower cisplatin doses were associated with less pronounced tissue alterations.
Related Concept Videos
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

